Breaking News

Multi-Country Monkeypox Outbreak Accelerates

June 18, 2022 • 4:14 pm CDT
(Vax Before Travel)

The World Health Organization (WHO) published an update yesterday regarding the global monkeypox virus outbreak. Since early May 2022, over forty-two countries have identified about 2,600 probable monkeypox patients.

This data represents about a 35% increase in cases in one week.

The WHO stated on June 17, 2022, 'Planned gatherings in areas where monkeypox cases have been detected can be safely maintained with a few precautions and sharing of information as required.'

As of June 18, 2022, while epidemiological investigations are ongoing, most reported monkeypox virus (MPXV) cases have presented through sexual health or other health services, with a history of travel primarily to countries in Europe and the U.K. rather than African countries.

Currently, MPXV transmission in apparently newly affected countries is primarily linked to recent sexual contacts. 

The WHO assesses the risk at the global level as moderate, and the risk for the general public remains low.

Furthermore, based on available information at this time, the 'WHO does not recommend that Member States adopt any  measures that interfere with international traffic for either incoming or outgoing travelers.'

This opinion is based on considering this is the first time MPXV clusters have been reported concurrently in geographically dispersed areas.

And balanced against the fact that mortality has remained low in the current outbreak.

Some WHO Member States are deploying the ACAM2000 and MVA-BN vaccines (Jynneos) to the close-contacts of these MPXV patients.

These vaccine's efficacy against this MPXV version has not been confirmed.

And the antiviral agent tecovirimat (TPOXX) has been approved in Canada, Europe, and the USA for treating smallpox and in the European Union for treating monkeypox.

The WHO has convened experts to review the latest data on monkeypox vaccines and provide guidance on how and in what circumstances they should be used.

The U.S. CDC recently stated in the USA, 'Monkeypox is a disease caused by a virus not commonly seen in the United States.'

Patients are usually ill for 2–4 weeks, and monkeypox can be a fatal disease.

As of June 17, 2022, the CDC reported (13) additional MPXV patients in just one day.

In total, twenty U.S. states have confirmed (113) patients since May 2022.

'While we work to contain the current outbreak and study the virus, we want you to have information so you can make informed choices when you are in spaces or situations where monkeypox could be spread through close, intimate contact or during sex.'

'There is a lot we still need to learn about monkeypox, and we will update this information as we learn more.'

The CDC missed an Alert - Level 2, Practice Enhanced Precautions, notice on June 7, 2022, to notify international travelers of their potential health risks.

Vax-Before-Travel posts additional monkeypox outbreak breaking news.

Note: This information was manually curated for mobile readers.